In a recent article published in CA: A Cancer Journal For Clinicians, the authors conducted a systematic review of the literature regarding the timing of follow-up diagnostic imaging of patients that are screened for breast, cervical, colorectal, and lung cancers. They found that, “The available evidence suggests an increased risk of cancer, later stage cancer, or mortality with increasing time between a positive cancer screening result and receipt of diagnostic testing.”

The HealthMyne Platform’s enhanced Clinical Decision Support (CDS) Workflows are specifically designed to help make sure patients get timely follow-up and treatment. For example, the Incidental Findings and Cancer Screening Workflows assist clinicians in determining the correct follow up based on accepted guidelines like Fleischner Criteria or those from the ACR and will notify the appropriate care teams when patients are overdue.

The full text article is available here.